dalfampridine ER
Marketedupdated 2mo agoby Mylan Pharmaceuticals Inc
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple sclerosis and 15 investigational indications.
indications
investigational
Multiple Sclerosis
all catalysts(3)
approval · 3
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that